查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1916656

全球生物活性胜肽和營養保健品成分市場預測至2032年：按來源、成分類型、劑型、作用機制、通路、應用和地區分類

Bioactive Peptides & Nutraceutical Ingredients Market Forecasts to 2032 - Global Analysis By Source, Ingredient Type, Form, Mechanism, Distribution Channel, Application, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，全球生物活性胜肽和營養保健成分市場預計將在 2025 年達到 591.2 億美元，並在 2032 年達到 980.9 億美元。

預計在預測期內，生物活性胜肽和營養保健成分食品將以7.5%的複合年成長率成長。這類食品不僅符合標準營養需求，還富含多種有益健康的化合物。生物活性胜肽來自蛋白質分解，在改善免疫反應、心臟健康、消化和新陳代謝方面發揮重要作用。益生菌、抗氧化劑、植物萃取物、維生素和礦物質等營養保健成分有助於促進健康和降低健康風險。這些食品融合了營養和治療功效，透過日常飲食攝入，支持長期健康、功能表現和預防保健。

世界人口老化

隨著消費族群老化，人們越來越傾向於選擇能夠支持健康老齡化、增強免疫功能、維持肌肉健康和提升認知功能的營養成分。生物活性胜肽因其在心血管健康、骨骼強健和代謝調節方面的益處而廣受認可。隨著預期壽命的延長，預防性營養比被動式醫療保健方案更受重視。富含胜肽的營養保健品正透過膳食補充劑和強化食品被納入日常飲食中。醫療保健專業人員也建議使用基於胜肽的營養來管理與老齡化相關的慢性疾病。這種人口結構的變化正在已開發國家和新興國家穩步擴大消費群。

生物有效性的複雜性

肽類物質極易受到消化酵素的影響，口服後可能降低其療效。因此，需要先進的包封和遞送技術來確保其在加工、儲存和消化過程中的穩定性。個體吸收率的差異進一步增加了產品標準化的難度。製造商必須投入大量資金進行臨床試驗以證實其療效。監管機構對功能性益處的審查也會增加研發時間和成本。這些技術和科學上的複雜性可能會阻礙胜肽類營養保健品的快速商業化。

植物來源與純素趨勢

出於倫理、環境和健康方面的考慮，消費者越來越傾向於尋找動物性胜肽的替代品。植物蛋白水解技術的進步使得從大豆、豌豆、米和藻類等來源開發高效肽成分成為可能。純素營養補充品在運動營養、體重管理和保健品領域正日益受到青睞。 「潔淨標示」趨勢也推動了天然生物活性化合物的應用。食品和補充劑品牌正在重新設計產品，以滿足彈性素食者和純素的需求。這種轉變正在擴大其在全球營養補充品市場的適用範圍。

來自合成替代品的競爭

合成替代品通常具有生產成本更低、配方穩定性更高的優勢。這些成分因其可進行工程改造以實現特定功能，而備受大眾市場製造商的青睞。此外，醫藥級合成化合物也受惠於完善的監管體系。另一方面，天然胜肽則需要大量的研究來證實其健康益處。價格敏感的市場可能更傾向於合成替代品而非生物基成分。這種競爭壓力可能會影響天然生物活性胜肽的市場滲透率。

新冠疫情的影響：

新冠疫情顯著影響了生物活性胜肽和營養保健品原料市場的需求模式。人們對免疫健康的日益關注帶動了機能性食品和膳食補充劑消費量的成長。供應鏈中斷初期影響了原料採購和生產營運。然而，數位化銷售管道和電商平台有效彌補了傳統零售通路的下滑。疫情期間，對增強免疫力胜肽的研究加速推進。監管機構也展現出柔軟性，並加快了某些膳食補充劑的核准。即使在疫情結束後，消費者依然重視預防性營養，這將維持市場的長期成長。

預計在預測期內，生物活性胜肽細分市場將佔據最大的市場佔有率。

由於肽類成分具有廣泛的生理效應，預計在預測期內，生物活性胜肽細分市場將佔據最大的市場佔有率。生物活性胜肽廣泛應用於針對心臟健康、肌肉恢復、消化和免疫功能的膳食補充劑。其在臨床和功能營養領域的確切療效贏得了消費者的信賴。酶水解和萃取技術的不斷進步正在提高胜肽的產量和性能。食品和飲料生產商正擴大將胜肽添加到功能性配方中。

預計在預測期內，化妝品和個人護理用品細分市場將呈現最高的複合年成長率。

預計在預測期內，化妝品和個人護理領域將保持最高的成長率。生物活性胜肽因其抗衰老、修復肌膚和促進膠原蛋白生成等功效而備受青睞。消費者對科學護膚方案的需求不斷成長，加速了胜肽產品的普及。天然和生物來源的化妝品成分比合成化學物質更受青睞。胜肽類產品廣泛應用於精華液、乳霜和針對特定肌膚問題的護膚配方中。高級產品和藥用化妝品產品類型的成長進一步推動了市場需求。

佔比最大的地區：

預計北美將在預測期內佔據最大的市場佔有率，這得益於該地區消費者對功能性營養和健康保健的高度重視。眾多膳食補充劑生產商和研究機構的存在，為產品創新提供了有力支撐。法律規範也促進了以科學為基礎的膳食補充劑的系統化商業化。較高的可支配收入推動了消費者在高階膳食補充劑和機能性食品的支出成長。運動營養和健康老化領域在該地區尤為強勁。

年複合成長率最高的地區：

在預測期內，亞太地區預計將成為複合年成長率最高的地區，這主要得益於快速的都市化和飲食習慣的改變。不斷壯大的中產階級正在加大對健康和保健解決方案的投資。傳統醫學體係也將生物活性胜肽融入現代膳食補充劑中。中國、日本、印度和韓國等國家正崛起為重要的成長市場。產能擴張和原料的在地採購有助於提高成本效益。

免費客製化服務：

購買此報告的客戶可以選擇以下免費自訂選項之一：

  • 公司概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 主要參與者（最多3家公司）的SWOT分析
  • 區域細分
    • 根據客戶要求，提供主要國家的市場估算和預測以及複合年成長率（註：可行性需確認）。
  • 競爭標竿分析
    • 基於產品系列、地域覆蓋範圍和策略聯盟對主要參與者進行基準分析

目錄

第1章執行摘要

第2章 前言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球生物活性胜肽和營養保健成分市場（按來源分類）

  • 植物來源蛋白質和胜肽
  • 動物源性蛋白質和胜肽
  • 海洋來源的蛋白質和胜肽
  • 發酵衍生胜肽
  • 合成胜肽和成分

6. 全球生物活性胜肽和營養保健成分市場（按成分類型分類）

  • 生物活性胜肽
    • 膠原蛋白肽
    • 牛奶和酪蛋白胜肽
    • 蛋胜肽
    • 大豆和植物胜肽
  • 胺基酸和蛋白質組分
  • 益生元和益生菌
  • 植物化學和植物萃取物
  • Omega-3脂肪酸衍生物
  • 維生素、礦物質和特殊營養素

7. 全球生物活性胜肽和營養保健成分市場（按形式分類）

  • 粉末
  • 液體
  • 膠囊
  • 其他

8. 全球生物活性胜肽和營養保健成分市場依作用機制分類

  • 抗氧化胜肽
  • 抗菌胜肽
  • 抗高血壓胜肽
  • 免疫調節胜肽
  • 抗發炎胜肽
  • 體重管理與代謝胜肽

9. 全球生物活性胜肽和營養保健成分市場（按分銷管道分類）

  • 直接B2B
  • 零售
    • 超級市場和大賣場
    • 專賣店
  • EC

第10章 全球生物活性胜肽和營養保健成分市場（按應用領域分類）

  • 營養補充品
  • 機能性食品和飲料
  • 藥物與臨床營養
  • 化妝品和個人護理
  • 動物營養與飼料
  • 其他

第11章 全球生物活性胜肽和營養保健成分市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第13章：企業概況

  • Arla Foods Ingredients Group P/S
  • Peptan
  • Kerry Group plc
  • Roquette Freres
  • Glanbia plc
  • Danone SA
  • Royal DSM NV
  • Nestle SA
  • BASF SE
  • Hilmar Ingredients
  • Cargill, Incorporated
  • FrieslandCampina
  • Ingredion Incorporated
  • Ajinomoto Co., Inc.
  • Archer Daniels Midland Company（ADM）
Product Code: SMRC33229

According to Stratistics MRC, the Global Bioactive Peptides & Nutraceutical Ingredients Market is accounted for $59.12 billion in 2025 and is expected to reach $98.09 billion by 2032 growing at a CAGR of 7.5% during the forecast period. Bioactive Peptides & Nutraceutical Ingredients Foods refer to advanced food products enriched with health-promoting compounds that go beyond meeting standard dietary needs. Bioactive peptides, obtained from protein breakdown, play roles in improving immune response, heart health, digestion, and metabolism. Nutraceutical ingredients such as probiotics, antioxidants, botanical extracts, vitamins, and minerals contribute to enhanced wellness and reduced health risks. These foods integrate nutrition with therapeutic benefits, supporting long-term health, functional performance, and preventive healthcare through everyday dietary consumption.

Market Dynamics:

Driver:

Aging global population

Older consumers are increasingly seeking functional ingredients that support healthy aging, immunity, muscle maintenance, and cognitive function. Bioactive peptides are widely recognized for their benefits in cardiovascular health, bone strength, and metabolic regulation. As life expectancy increases, preventive nutrition is becoming a priority over reactive healthcare solutions. Nutraceutical formulations enriched with peptides are being incorporated into daily diets through supplements and fortified foods. Healthcare professionals are also recommending peptide-based nutrition to manage age-related chronic conditions. This demographic shift is steadily expanding the consumer base across both developed and emerging economies.

Restraint:

Complexity of bioavailability

Peptides are highly sensitive to digestive enzymes, which can reduce their efficacy when consumed orally. Ensuring stability during processing, storage, and digestion requires advanced encapsulation and delivery technologies. Variability in absorption rates among individuals further complicates product standardization. Manufacturers must invest heavily in clinical validation to demonstrate efficacy claims. Regulatory scrutiny around functional benefits also increases development timelines and costs. These technical and scientific complexities can restrain faster commercialization of peptide-based nutraceuticals.

Opportunity:

Plant-based & vegan shift

Consumers are increasingly demanding alternatives to animal-derived peptides due to ethical, environmental, and health concerns. Advances in plant protein hydrolysis are enabling the development of effective peptide ingredients from sources such as soy, peas, rice, and algae. Vegan nutraceuticals are gaining traction in sports nutrition, weight management, and wellness supplements. Clean-label trends are further supporting the adoption of naturally derived bioactive compounds. Food and supplement brands are reformulating products to cater to flexitarian and vegan consumers. This transition is expanding application potential across global nutraceutical markets.

Threat:

Competition from synthetic alternatives

Synthetic alternatives often offer lower production costs and higher formulation stability. These ingredients can be engineered for targeted functionality, making them attractive to mass-market manufacturers. Pharmaceutical-grade synthetic compounds also benefit from well-established regulatory pathways. In comparison, natural peptides require extensive research to validate health claims. Price-sensitive markets may prefer synthetic substitutes over bio-based ingredients. This competitive pressure can impact market penetration for naturally sourced bioactive peptides.

Covid-19 Impact:

The COVID-19 pandemic significantly influenced demand patterns in the bioactive peptides and nutraceutical ingredients market. Heightened awareness of immune health led to increased consumption of functional foods and dietary supplements. Supply chain disruptions initially affected raw material sourcing and manufacturing operations. However, digital sales channels and e-commerce platforms helped offset traditional retail slowdowns. Research activities related to immunity-enhancing peptides accelerated during the pandemic period. Regulatory agencies also showed flexibility in fast-tracking certain nutraceutical approvals. Post-pandemic, consumers continue to prioritize preventive nutrition, sustaining long-term market growth.

The bioactive peptides segment is expected to be the largest during the forecast period

The bioactive peptides segment is expected to account for the largest market share during the forecast period, driven by the wide range of physiological benefits associated with peptide-based ingredients. Bioactive peptides are extensively used in supplements targeting heart health, muscle recovery, digestion, and immunity. Their proven efficacy in clinical and functional nutrition applications supports strong consumer trust. Ongoing advancements in enzymatic hydrolysis and extraction technologies are improving peptide yield and performance. Food and beverage manufacturers are increasingly incorporating peptides into functional formulations.

The cosmetic & personal care segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cosmetic & personal care segment is predicted to witness the highest growth rate. Bioactive peptides are gaining popularity for their anti-aging, skin repair, and collagen-boosting properties. Increasing consumer demand for science-backed skincare solutions is accelerating peptide adoption. Natural and bio-derived cosmetic ingredients are preferred over synthetic chemicals. Peptides are widely used in serums, creams, and dermal formulations for targeted skin benefits. Growth in premium and cosmeceutical product categories is further driving demand.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the region benefits from high consumer awareness regarding functional nutrition and preventive healthcare. Strong presence of nutraceutical manufacturers and research institutions supports product innovation. Regulatory frameworks allow structured commercialization of evidence-backed nutraceuticals. High disposable incomes enable greater spending on premium supplements and functional foods. The sports nutrition and healthy aging segments are particularly strong in this region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to rapid urbanization and changing dietary habits. Rising middle-class populations are increasingly investing in health and wellness solutions. Traditional medicine systems are also integrating bioactive peptides into modern nutraceutical formats. Countries such as China, Japan, India, and South Korea are emerging as key growth markets. Expanding manufacturing capabilities and local sourcing of raw materials support cost efficiency.

Key players in the market

Some of the key players in Bioactive Peptides & Nutraceutical Ingredients Market include Arla Foods Ingredients Group P/S, Peptan, Kerry Group plc, Roquette Freres, Glanbia plc, Danone S.A., Royal DSM N.V., Nestle S.A., BASF SE, Hilmar Ingredients, Cargill, Incorporated, FrieslandCampina, Ingredion Incorporated, Ajinomoto Co., Inc., and Archer Daniels Midland Company (ADM).

Key Developments:

In December 2025, BASF, San Fang Chemical Industrial Co., Ltd. and Nichetech Advanced Materials Co., Ltd. have signed a Memorandum of Understanding (MoU) to jointly develop sustainable solutions for the footwear industry, with a focus on thermoplastic polyurethane (TPU) products and a shared ambition to achieve net-zero carbon emissions by 2050.

In October 2025, Mars and Cargill, announced they are spurring the development of more than 224MWac* of new renewable energy capacity through five virtual power purchase agreements (PPAs) in Poland. The PPAs were signed with GoldenPeaks Capital, one of Europe's fastest-growing independent producers of renewable energy.

Sources Covered:

  • Plant-Derived Proteins & Peptides
  • Animal-Derived Proteins & Peptides
  • Marine-Derived Proteins & Peptides
  • Fermentation-Derived Peptides
  • Synthetic Peptides & Ingredients

Ingredient Types Covered:

  • Bioactive Peptides
  • Amino Acids & Protein Fractions
  • Prebiotics & Probiotics
  • Phytochemicals & Plant Extracts
  • Omega-3 & Fatty Acid Derivatives
  • Vitamins, Minerals & Specialty Nutrients

Forms Covered:

  • Powder
  • Liquid
  • Capsules
  • Other Foams

Mechanisms Covered:

  • Antioxidant Peptides
  • Antimicrobial Peptides
  • Antihypertensive
  • Immune-Regulating Peptides
  • Anti-Inflammatory
  • Weight Management & Metabolic Peptides

Distribution Channels Covered:

  • Direct B2B
  • Retail
  • E-Commerce

Applications Covered:

  • Nutraceuticals & Dietary Supplements
  • Functional Food & Beverages
  • Pharmaceuticals & Clinical Nutrition
  • Cosmetic & Personal Care
  • Animal Nutrition & Feed
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Source

  • 5.1 Introduction
  • 5.2 Plant Derived Proteins & Peptides
  • 5.3 Animal Derived Proteins & Peptides
  • 5.4 Marine Derived Proteins & Peptides
  • 5.5 Fermentation Derived Peptides
  • 5.6 Synthetic Peptides & Ingredients

6 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Ingredient Type

  • 6.1 Introduction
  • 6.2 Bioactive Peptides
    • 6.2.1 Collagen Peptides
    • 6.2.2 Milk & Casein Peptides
    • 6.2.3 Egg Peptides
    • 6.2.4 Soy & Plant Peptides
  • 6.3 Amino Acids & Protein Fractions
  • 6.4 Prebiotics & Probiotics
  • 6.5 Phytochemicals & Plant Extracts
  • 6.6 Omega 3 & Fatty Acid Derivatives
  • 6.7 Vitamins, Minerals & Specialty Nutrients

7 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Form

  • 7.1 Introduction
  • 7.2 Powder
  • 7.3 Liquid
  • 7.4 Capsules
  • 7.5 Other Foams

8 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Mechanism

  • 8.1 Introduction
  • 8.2 Antioxidant Peptides
  • 8.3 Antimicrobial Peptides
  • 8.4 Antihypertensive
  • 8.5 Immune Regulating Peptides
  • 8.6 Anti Inflammatory
  • 8.7 Weight Management & Metabolic Peptides

9 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Direct B2B
  • 9.3 Retail
    • 9.3.1 Supermarkets & Hypermarkets
    • 9.3.2 Specialty Stores
  • 9.4 E Commerce

10 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Application

  • 10.1 Introduction
  • 10.2 Nutraceuticals & Dietary Supplements
  • 10.3 Functional Food & Beverages
  • 10.4 Pharmaceuticals & Clinical Nutrition
  • 10.5 Cosmetic & Personal Care
  • 10.6 Animal Nutrition & Feed
  • 10.7 Other Applications

11 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Arla Foods Ingredients Group P/S
  • 13.2 Peptan
  • 13.3 Kerry Group plc
  • 13.4 Roquette Freres
  • 13.5 Glanbia plc
  • 13.6 Danone S.A.
  • 13.7 Royal DSM N.V.
  • 13.8 Nestle S.A.
  • 13.9 BASF SE
  • 13.10 Hilmar Ingredients
  • 13.11 Cargill, Incorporated
  • 13.12 FrieslandCampina
  • 13.13 Ingredion Incorporated
  • 13.14 Ajinomoto Co., Inc.
  • 13.15 Archer Daniels Midland Company (ADM)

List of Tables

  • Table 1 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Source (2024-2032) ($MN)
  • Table 3 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Plant Derived Proteins & Peptides (2024-2032) ($MN)
  • Table 4 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Animal Derived Proteins & Peptides (2024-2032) ($MN)
  • Table 5 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Marine Derived Proteins & Peptides (2024-2032) ($MN)
  • Table 6 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Fermentation Derived Peptides (2024-2032) ($MN)
  • Table 7 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Synthetic Peptides & Ingredients (2024-2032) ($MN)
  • Table 8 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Ingredient Type (2024-2032) ($MN)
  • Table 9 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Bioactive Peptides (2024-2032) ($MN)
  • Table 10 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Collagen Peptides (2024-2032) ($MN)
  • Table 11 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Milk & Casein Peptides (2024-2032) ($MN)
  • Table 12 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Egg Peptides (2024-2032) ($MN)
  • Table 13 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Soy & Plant Peptides (2024-2032) ($MN)
  • Table 14 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Amino Acids & Protein Fractions (2024-2032) ($MN)
  • Table 15 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Prebiotics & Probiotics (2024-2032) ($MN)
  • Table 16 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Phytochemicals & Plant Extracts (2024-2032) ($MN)
  • Table 17 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Omega 3 & Fatty Acid Derivatives (2024-2032) ($MN)
  • Table 18 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Vitamins, Minerals & Specialty Nutrients (2024-2032) ($MN)
  • Table 19 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Form (2024-2032) ($MN)
  • Table 20 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Powder (2024-2032) ($MN)
  • Table 21 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Liquid (2024-2032) ($MN)
  • Table 22 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Capsules (2024-2032) ($MN)
  • Table 23 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Other Foams (2024-2032) ($MN)
  • Table 24 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Mechanism (2024-2032) ($MN)
  • Table 25 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Antioxidant Peptides (2024-2032) ($MN)
  • Table 26 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Antimicrobial Peptides (2024-2032) ($MN)
  • Table 27 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Antihypertensive (2024-2032) ($MN)
  • Table 28 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Immune Regulating Peptides (2024-2032) ($MN)
  • Table 29 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Anti Inflammatory (2024-2032) ($MN)
  • Table 30 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Weight Management & Metabolic Peptides (2024-2032) ($MN)
  • Table 31 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 32 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Direct B2B (2024-2032) ($MN)
  • Table 33 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Retail (2024-2032) ($MN)
  • Table 34 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Supermarkets & Hypermarkets (2024-2032) ($MN)
  • Table 35 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Specialty Stores (2024-2032) ($MN)
  • Table 36 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By E Commerce (2024-2032) ($MN)
  • Table 37 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Application (2024-2032) ($MN)
  • Table 38 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Nutraceuticals & Dietary Supplements (2024-2032) ($MN)
  • Table 39 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Functional Food & Beverages (2024-2032) ($MN)
  • Table 40 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Pharmaceuticals & Clinical Nutrition (2024-2032) ($MN)
  • Table 41 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Cosmetic & Personal Care (2024-2032) ($MN)
  • Table 42 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Animal Nutrition & Feed (2024-2032) ($MN)
  • Table 43 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Other Applications (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.